ARCHIVES

Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 40 No. 47 | December 19, 2014

Download PDF Visit The Full Archive

Related Articles

ASRO President Tells Colleagues To Take Charge

October 26, 1990

NCI Get Go-Ahead For New Cancer Control Projects Totaling $7.4 Million, Funded By Grants, Contracts

October 21, 1977

Avoiding Mediastinal Radiation Can Improve Patient Outcomes

April 26, 2013

Gonzalez-Angulo Found Guilty in MD Anderson Poisoning Case

September 26, 2014

Asks BSC For Advice On Centers Funding, Other Pressing Issues, But Doesn’t Get Any

March 30, 1990

Accrediting Agency Places Dana-Farber On Probation

April 21, 1995